---
category: news
title: "The 3 Most Undervalued AI Stocks to Buy in September 2023"
excerpt: "InvestorPlace - Stock Market News, Stock Advice & Trading Tips Although artificial intelligence has garnered tremendous interest for good"
publishedDateTime: 2023-09-16T18:51:00Z
originalUrl: "https://markets.businessinsider.com/news/stocks/the-3-most-undervalued-ai-stocks-to-buy-in-september-2023-1032634932"
webUrl: "https://markets.businessinsider.com/news/stocks/the-3-most-undervalued-ai-stocks-to-buy-in-september-2023-1032634932"
type: article
quality: 47
heat: -1
published: false

provider:
  name: Business Insider
  domain: businessinsider.com
  images:
    - url: "https://everyday-cc.github.io/ai/assets/images/organizations/businessinsider.com-50x50.jpg"
      width: 50
      height: 50

topics:
  - AI

related:
  - title: "The 3 Most Undervalued AI Penny Stocks to Buy in September 2023"
    excerpt: "InvestorPlace - Stock Market News, Stock Advice & Trading Tips Every savvy investor is looking for that golden opportunity in the dawn of the"
    publishedDateTime: 2023-09-14T12:28:00Z
    webUrl: "https://markets.businessinsider.com/news/stocks/the-3-most-undervalued-ai-penny-stocks-to-buy-in-september-2023-1032630335"
    type: article
    provider:
      name: Business Insider
      domain: businessinsider.com
    quality: 49
  - title: "The 3 Most Undervalued Machine Learning Stocks to Buy in September 2023"
    excerpt: "InvestorPlace - Stock Market News, Stock Advice & Trading Tips If you’re wondering if there is still time to invest in machine learning"
    publishedDateTime: 2023-09-14T13:09:00Z
    webUrl: "https://markets.businessinsider.com/news/stocks/3-machine-learning-stocks-that-are-flying-under-the-radar-1032630601"
    type: article
    provider:
      name: Business Insider
      domain: businessinsider.com
    quality: 49
  - title: "Kiromic BioPharma Common Stock to Begin Trading on the OTC Pink Sheets on September 14"
    excerpt: "Kiromic BioPharma (NASDAQ: KRBP) (“Kiromic” or the “Company”), a clinical-stage, fully-integrated biotherapeutics company using its proprietary DIAMON"
    publishedDateTime: 2023-09-13T20:35:00Z
    webUrl: "https://www.businesswire.com/news/home/20230913097444/en/"
    type: article
    provider:
      name: Business Wire
      domain: businesswire.com
    quality: 0

secured: "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;qvHcdvD7ENsOaSYXmydhrw=="
---

